Marker Therapeutics, Inc. (MRKR) AI Dilution Summary
Updated Sep 27, 2026
Cash was $11,922,332 at 2026-06-30 against estimated monthly burn of $800,893. The funding channel in place is an active at-the-market program with H.C. Wainwright & Co. LLC, authorised to $11,431,731, with $0 sold to date. Dilution here is driven primarily by that ATM program.